| Literature DB >> 33217969 |
Sai Karthik Kodeboyina1, Tae Jin Lee1, Lara Churchwell1, Lane Ulrich2, Kathryn Bollinger2, David Bogorad2, Amy Estes2, Wenbo Zhi1, Shruti Sharma1,2, Ashok Sharma1,2,3.
Abstract
Aqueous humor (AH) is the fluid in the anterior and posterior chambers of the eye that contains proteins regulating ocular homeostasis. Analysis of aqueous humor proteome is challenging, mainly due to low sample volume and protein concentration. In this study, by utilizing state of the art technology, we performed Liquid-Chromatography Mass spectrometry (LC-MS/MS) analysis of 88 aqueous humor samples from subjects undergoing cataract surgery. A total of 2263 unique proteins were identified, which were sub-divided into four categories that were based on their detection in the number of samples: High (n = 152), Medium (n = 91), Low (n = 128), and Rare (n = 1892). A total of 243 proteins detected in at least 50% of the samples were considered as the constitutive proteome of human aqueous humor. The biological processes and pathways enriched in the AH proteins mainly include vesicle mediated transport, acute phase response signaling, LXR/RXR activation, complement system, and secretion. The enriched molecular functions are endopeptidase activity, and various binding functions, such as protein binding, lipid binding, and ion binding. Additionally, this study provides a novel insight into race specific differences in the AH proteome. A total of six proteins were upregulated, and five proteins were downregulated in African American subjects as compared to Caucasians.Entities:
Keywords: aqueous humor; mass spectrometry; proteomics
Year: 2020 PMID: 33217969 PMCID: PMC7709111 DOI: 10.3390/proteomes8040034
Source DB: PubMed Journal: Proteomes ISSN: 2227-7382
Characteristics of study participants.
| Characteristics | Count |
|---|---|
| Subjects, ( | 88 |
| Sex: F/M | 55/33 |
| Age (years) | 67.0 ± 9.56 |
| Race: AA/Caucasian | 66/22 |
| Hypertension, N/Y | 41/47 |
| Smoking, N/Y | 56/32 |
| Cardiovascular disease, N/Y | 81/7 |
| Cerebrovascular disease, N/Y | 87/1 |
| Collagen vascular disease, N/Y | 75/13 |
| Intraocular Pressure (IOP) | 19.5 ± 7.01 |
Figure 1Liquid chromatography/Mass Spectrometry (LC-MS/MS) workflow for proteomic analysis of human aqueous humor. Samples were digested using trypsin and were analyzed using an Orbitrap Fusion Tribrid mass spectrometer coupled with an Ultimate 3000 nano-UPLC system. Proteins were identified and quantified using Proteome Discoverer (ver 1.4; Thermo Scientific, Waltham, MA, USA) followed by statistical analysis using the R Project for statistical computing (https://www.r-project.org/).
Figure 2Example of LC-MS/MS analysis of human aqueous humor sample. (A) LC-MS/MS total ion current chromatogram. The retention time (RT) elution of one reporter peptide indicative of A2M protein is marked for illustration purposes. (B) MS spectra of selected precursor peptide 444.78 m/z with a distinct isotopic pattern benefitted from the high resolution of the Orbitrap MS analyzer. (C) MS/MS spectra using collision-induced dissociation (CID) fragmentation of A2M (444.78 m/z) precursor peptide, colored peaks (red for b ions and blue for y ions) indicate matches between experimental and theoretical/calculated values.
Figure 3Distribution of the mean values (A) and coefficient of variation (B) of proteins detected in the human aqueous humor samples. The proteins were subdivided into four categories, based on their detection rate. High: detected in >75%; Medium: detected in 50–75%; Low: detected in 25–50%; Rare: detected in <25% of the samples. Coefficient of variation decreases as mean protein expression increases.
Most abundant proteins present in the human aqueous humor.
| Uniprot ID | Gene Symbol | Description | Detected in Proportion of Samples (%) | Mean PSM Value |
|---|---|---|---|---|
| P02768 | ALB | Albumin | 100.00 | 4202.61 |
| P02787 | TF | Serotransferrin | 100.00 | 765.31 |
| P01024 | C3 | Complement C3 | 100.00 | 255.00 |
| P01009 | SERPINA1 | Alpha-1-antitrypsin | 100.00 | 233.24 |
| P02790 | HPX | Hemopexin | 100.00 | 176.64 |
| P01859 | IGHG2 | Immunoglobulin heavy constant gamma 2 | 100.00 | 168.92 |
| P10745 | RBP3 | Retinol-binding protein 3 | 100.00 | 166.25 |
| P00450 | CP | Ceruloplasmin | 100.00 | 165.20 |
| P01834 | IGKC | Immunoglobulin kappa constant | 100.00 | 161.42 |
| P02766 | TTR | Transthyretin | 100.00 | 156.30 |
| P41222 | PTGDS | Prostaglandin-H2 D-isomerase | 100.00 | 142.25 |
| P36955 | SERPINF1 | Pigment epithelium-derived factor | 100.00 | 141.33 |
| P01860 | IGHG3 | Immunoglobulin heavy constant gamma 3 | 100.00 | 127.65 |
| P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | 100.00 | 119.16 |
| P02774 | GC | Vitamin D-binding protein | 100.00 | 115.89 |
| P0DOX7 | N/A | Immunoglobulin kappa light chain | 100.00 | 108.22 |
| P10909 | CLU | Clusterin | 100.00 | 102.33 |
| P02647 | APOA1 | Apolipoprotein A-I | 100.00 | 96.78 |
| P01034 | CST3 | Cystatin-C | 100.00 | 82.73 |
| P02765 | AHSG | Alpha-2-HS-glycoprotein | 100.00 | 73.27 |
| P01023 | A2M | Alpha-2-macroglobulin | 100.00 | 72.77 |
| P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | 100.00 | 68.70 |
| P06396 | GSN | Gelsolin | 100.00 | 62.66 |
| P01008 | SERPINC1 | Antithrombin-III | 100.00 | 62.65 |
| P02749 | APOH | Beta-2-glycoprotein 1 | 100.00 | 59.09 |
| P04217 | A1BG | Alpha-1B-glycoprotein | 100.00 | 59.04 |
| P22352 | GPX3 | Glutathione peroxidase 3 | 100.00 | 58.23 |
| Q9UBP4 | DKK3 | Dickkopf-related protein 3 | 100.00 | 56.91 |
| P01011 | SERPINA3 | Alpha-1-antichymotrypsin | 100.00 | 53.15 |
| P01876 | IGHA1 | Immunoglobulin heavy constant alpha 1 | 100.00 | 51.83 |
| Q12805 | EFEMP1 | EGF-containing fibulin-like extracellular matrix protein 1 | 100.00 | 50.79 |
| P00751 | CFB | Complement factor B | 100.00 | 50.35 |
| Q13822 | ENPP2 | Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | 100.00 | 45.77 |
| P00747 | PLG | Plasminogen | 100.00 | 45.45 |
| Q9UBM4 | OPTC | Opticin | 100.00 | 43.07 |
| P07339 | CTSD | Cathepsin D | 100.00 | 39.10 |
| P00734 | F2 | Prothrombin | 100.00 | 38.21 |
| P05155 | SERPING1 | Plasma protease C1 inhibitor | 100.00 | 35.94 |
| P10451 | SPP1 | Osteopontin | 100.00 | 35.94 |
| P06727 | APOA4 | Apolipoprotein A-IV | 100.00 | 33.93 |
| P02649 | APOE | Apolipoprotein E | 100.00 | 32.43 |
| P01042 | KNG1 | Kininogen-1 | 100.00 | 30.10 |
| P04196 | HRG | Histidine-rich glycoprotein | 100.00 | 29.90 |
| P25311 | AZGP1 | Zinc-alpha-2-glycoprotein | 100.00 | 29.67 |
| P07998 | RNASE1 | Ribonuclease pancreatic | 100.00 | 29.30 |
| O94985 | CLSTN1 | Calsyntenin-1 | 100.00 | 27.54 |
| P01019 | AGT | Angiotensinogen | 100.00 | 26.00 |
| P02760 | AMBP | Protein AMBP | 100.00 | 24.23 |
| P02652 | APOA2 | Apolipoprotein A-II | 100.00 | 20.83 |
| P36222 | CHI3L1 | Chitinase-3-like protein 1 | 100.00 | 20.03 |
| P23142 | FBLN1 | Fibulin-1 | 100.00 | 19.91 |
| P02750 | LRG1 | Leucine-rich alpha-2-glycoprotein | 100.00 | 18.87 |
| P05156 | CFI | Complement factor I | 100.00 | 18.82 |
| P02753 | RBP4 | Retinol-binding protein 4 | 100.00 | 17.09 |
| P04004 | VTN | Vitronectin | 100.00 | 16.58 |
| Q16270 | IGFBP7 | Insulin-like growth factor-binding protein 7 | 100.00 | 15.10 |
| P51884 | LUM | Lumican | 100.00 | 13.89 |
| P00746 | CFD | Complement factor D | 100.00 | 13.10 |
| P05090 | APOD | Apolipoprotein D | 100.00 | 12.66 |
| O43505 | B4GAT1 | Beta-1,4-glucuronyltransferase 1 | 100.00 | 12.09 |
| P24592 | IGFBP6 | Insulin-like growth factor-binding protein 6 | 100.00 | 11.28 |
| Q96PD5 | PGLYRP2 | N-acetylmuramoyl-L-alanine amidase | 100.00 | 11.19 |
| Q14515 | SPARCL1 | SPARC-like protein 1 | 100.00 | 11.01 |
| P61916 | NPC2 | NPC intracellular cholesterol transporter 2 | 100.00 | 9.57 |
| Q99969 | RARRES2 | Retinoic acid receptor responder protein 2 | 100.00 | 8.03 |
| P61769 | B2M | Beta-2-microglobulin | 100.00 | 7.77 |
| Q99714 | HSD17B10 | 3-hydroxyacyl-CoA dehydrogenase type-2 | 100.00 | 7.61 |
| Q06481 | APLP2 | Amyloid-like protein 2 | 98.86 | 30.95 |
| P43652 | AFM | Afamin | 98.86 | 17.18 |
| Q8IZJ3 | CPAMD8 | C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 | 98.86 | 17.14 |
| Q14767 | LTBP2 | Latent-transforming growth factor beta-binding protein 2 | 98.86 | 15.82 |
| Q15582 | TGFBI | Transforming growth factor-beta-induced protein ig-h3 | 98.86 | 14.68 |
| Q9Y5W5 | WIF1 | Wnt inhibitory factor 1 | 98.86 | 14.39 |
| Q08629 | SPOCK1 | Testican-1 | 98.86 | 8.93 |
| P07602 | PSAP | Prosaposin | 98.86 | 7.48 |
| Q08380 | LGALS3BP | Galectin-3-binding protein | 98.86 | 6.67 |
| P00748 | F12 | Coagulation factor XII | 98.86 | 6.06 |
| P0DOY2 | IGLC2 | Immunoglobulin lambda constant 2 | 97.73 | 75.13 |
| P16870 | CPE | Carboxypeptidase E | 97.73 | 18.17 |
| Q9HCB6 | SPON1 | Spondin-1 | 97.73 | 10.63 |
| P06312 | IGKV4-1 | Immunoglobulin kappa variable 4-1 | 97.73 | 6.06 |
| P51888 | PRELP | Prolargin | 97.73 | 5.19 |
| P0DOX8 | N/A | Immunoglobulin lambda-1 light chain | 96.59 | 64.10 |
| P00738 | HP | Haptoglobin | 96.59 | 43.35 |
| P08603 | CFH | Complement factor H | 96.59 | 20.12 |
| Q8NG11 | TSPAN14 | Tetraspanin-14 | 96.59 | 17.09 |
| Q14624 | ITIH4 | Inter-alpha-trypsin inhibitor heavy chain H4 | 96.59 | 14.89 |
| Q99972 | MYOC | Myocilin | 96.59 | 8.76 |
| Q9NQ79 | CRTAC1 | Cartilage acidic protein 1 | 96.59 | 8.24 |
| P01861 | IGHG4 | Immunoglobulin heavy constant gamma 4 | 95.45 | 99.95 |
| P35555 | FBN1 | Fibrillin-1 | 95.45 | 12.27 |
| Q9BSG5 | RTBDN | Retbindin | 95.45 | 6.64 |
| P05452 | CLEC3B | Tetranectin | 95.45 | 6.41 |
| Q92520 | FAM3C | Protein FAM3C | 95.45 | 5.67 |
| Q86UP8 | GTF2IRD2 | General transcription factor II-I repeat domain-containing protein 2A | 95.45 | 5.51 |
| P02748 | C9 | Complement component C9 | 94.32 | 13.93 |
| O14773 | TPP1 | Tripeptidyl-peptidase 1 | 94.32 | 5.24 |
| P01033 | TIMP1 | Metalloproteinase inhibitor 1 | 94.32 | 3.64 |
| Q15113 | PCOLCE | Procollagen C-endopeptidase enhancer 1 | 94.32 | 3.45 |
| P01700 | IGLV1-47 | Immunoglobulin lambda variable 1-47 | 93.18 | 4.61 |
| P0C0L5 | C4B | Complement C4-B | 92.05 | 124.58 |
| P08697 | SERPINF2 | Alpha-2-antiplasmin | 92.05 | 9.18 |
| A0A0C4DH25 | IGKV3D-20 | Immunoglobulin kappa variable 3D-20 | 92.05 | 6.28 |
| P10643 | C7 | Complement component C7 | 92.05 | 4.08 |
| P19022 | CDH2 | Cadherin-2 | 92.05 | 3.83 |
| P19823 | ITIH2 | Inter-alpha-trypsin inhibitor heavy chain H2 | 90.91 | 10.06 |
| Q5T3U5 | ABCC10 | Multidrug resistance-associated protein 7 | 90.91 | 5.73 |
| P51693 | APLP1 | Amyloid-like protein 1 | 89.77 | 4.08 |
| P07357 | C8A | Complement component C8 alpha chain | 89.77 | 3.88 |
| P20273 | CD22 | B-cell receptor CD22 | 88.64 | 15.02 |
| P98160 | HSPG2 | Basement membrane-specific heparan sulfate proteoglycan core protein | 88.64 | 5.82 |
| Q5T8P6 | RBM26 | RNA-binding protein 26 | 88.64 | 4.68 |
| Q9Y287 | ITM2B | Integral membrane protein 2B | 88.64 | 3.43 |
| P39060 | COL18A1 | Collagen alpha-1(XVIII) chain | 88.64 | 2.36 |
| P18065 | IGFBP2 | Insulin-like growth factor-binding protein 2 | 87.50 | 3.78 |
| P10645 | CHGA | Chromogranin-A | 87.50 | 3.71 |
| P05067 | APP | Amyloid-beta precursor protein | 86.36 | 10.08 |
| P08294 | SOD3 | Extracellular superoxide dismutase [Cu-Zn] | 86.36 | 5.86 |
| Q92765 | FRZB | Secreted frizzled-related protein 3 | 86.36 | 4.79 |
| Q96S96 | PEBP4 | Phosphatidylethanolamine-binding protein 4 | 86.36 | 3.76 |
| P01780 | IGHV3-7 | Immunoglobulin heavy variable 3-7 | 85.23 | 4.97 |
| Q9HCJ0 | TNRC6C | Trinucleotide repeat-containing gene 6C protein | 85.23 | 3.70 |
| O15240 | VGF | Neurosecretory protein VGF | 85.23 | 2.74 |
| P02675 | FGB | Fibrinogen beta chain | 84.09 | 6.75 |
| P55083 | MFAP4 | Microfibril-associated glycoprotein 4 | 84.09 | 2.81 |
| P22914 | CRYGS | Gamma-crystallin S | 82.95 | 6.40 |
| P00441 | SOD1 | Superoxide dismutase [Cu-Zn] | 82.95 | 2.84 |
| P34096 | RNASE4 | Ribonuclease 4 | 82.95 | 1.81 |
| Q9Y6R7 | FCGBP | IgGFc-binding protein | 81.82 | 6.89 |
| O75326 | SEMA7A | Semaphorin-7A | 81.82 | 5.49 |
| P00736 | C1R | Complement C1r subcomponent | 81.82 | 4.49 |
| Q9BZV3 | IMPG2 | Interphotoreceptor matrix proteoglycan 2 | 80.68 | 3.07 |
| A0A087WSY6 | IGKV3D-15 | Immunoglobulin kappa variable 3D-15 | 80.68 | 2.17 |
| P61626 | LYZ | Lysozyme C | 79.55 | 4.83 |
| P43251 | BTD | Biotinidase | 79.55 | 2.71 |
| P06733 | ENO1 | Alpha-enolase | 78.41 | 12.05 |
| P29622 | SERPINA4 | Kallistatin | 78.41 | 5.03 |
| P05546 | SERPIND1 | Heparin cofactor 2 | 78.41 | 5.03 |
| P08185 | SERPINA6 | Corticosteroid-binding globulin | 78.41 | 3.86 |
| Q7Z7G0 | ABI3BP | Target of Nesh-SH3 | 78.41 | 2.72 |
| P04406 | GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | 77.27 | 5.63 |
| P01593 | IGKV1D-33 | Immunoglobulin kappa variable 1D-33 | 77.27 | 2.93 |
| P02679 | FGG | Fibrinogen gamma chain | 76.14 | 4.92 |
| Q66K66 | TMEM198 | Transmembrane protein 198 | 76.14 | 4.40 |
| P02656 | APOC3 | Apolipoprotein C-III | 76.14 | 3.19 |
| P13671 | C6 | Complement component C6 | 76.14 | 2.96 |
| Q99574 | SERPINI1 | Neuroserpin | 76.14 | 2.38 |
| P04264 | KRT1 | Keratin, type II cytoskeletal 1 | 75.00 | 36.86 |
| Q9UHG2 | PCSK1N | ProSAAS | 75.00 | 3.28 |
| P08571 | CD14 | Monocyte differentiation antigen CD14 | 75.00 | 2.48 |
| Q86UD1 | OAF | Out at first protein homolog | 75.00 | 2.12 |
| P98164 | LRP2 | Low-density lipoprotein receptor-related protein 2 | 75.00 | 1.84 |
Five most abundant protein families in the human aqueous humor.
| Family | Level | Proteins | ||||
|---|---|---|---|---|---|---|
| Apolipoproteins | High | APOA1 | APOA2 | APOA4 | APOC3 | APOD |
| APOE | APOH | |||||
| Medium | ||||||
| Low | ||||||
| Rare | APOB | APOC1 | APOF | APOL1 | APOLD1 | |
| Complement Proteins | High | C1R | C3 | C4B | C6 | C7 |
| C8A | C9 | CFB | CFD | CFH | ||
| CFI | ||||||
| Medium | C1S | C2 | C4A | C5 | C8B | |
| C8G | ||||||
| Low | C1QC | CFHR1 | CFHR2 | |||
| Rare | C1QB | C1QTNF6 | C1QTNF7 | C1RL | CD55 | |
| Immunoglobulins | High | IGHA1 | IGHG2 | IGHG3 | IGHG4 | IGHV3-7 |
| IGKC | IGKV1D-33 | IGKV3D-15 | IGKV3D-20 | IGKV4-1 | ||
| IGLC2 | IGLV1-47 | |||||
| Medium | IGHV3-49 | IGHV5-51 | IGHV6-1 | IGKV1-8 | IGKV2-28 | |
| IGLV1-40 | IGLV3-9 | |||||
| Low | IGHG1 | IGHM | IGHV3-66 | IGHV4-59 | IGKV1-6 | |
| IGKV1D-13 | IGKV3D-11 | IGLV6-57 | ||||
| Rare | IGDCC4 | IGHA2 | IGHV1-2 | IGHV1-3 | IGHV1-18 | |
| IGHV1-46 | IGHV1-69 | IGHV2-26 | IGHV2-70D | IGHV3-9 | ||
| IGHV3-15 | IGHV3-64D | IGHV3-72 | IGHV3-74 | IGKV1-5 | ||
| IGKV1-16 | IGKV1-17 | IGKV1-27 | IGKV3-11 | IGKV3-20 | ||
| IGLV1-44 | IGLV1-51 | IGLV2-11 | IGLV2-14 | IGLV2-18 | ||
| IGLV3-10 | IGLV3-19 | IGLV3-21 | IGSF10 | IGSF21 | ||
| IGSF22 | ILDR1 | ISLR | JCHAIN | |||
| Insulin Growth Factor (IGF) Family | High | IGFBP2 | IGFBP6 | IGFBP7 | ||
| Medium | IGF2 | IGFBP5 | ||||
| Low | IGFALS | IGFBP3 | ||||
| Rare | IGF1R | IGF2BP1 | IGFBP4 | |||
| Serine Protease Inhibitors (SERPINs) | High | SERPINA1 | SERPINA3 | SERPINA4 | SERPINA6 | SERPINC1 |
| SERPIND1 | SERPINF1 | SERPINF2 | SERPING1 | SERPINI1 | ||
| Medium | SERPINA5 | SERPINA7 | ||||
| Low | ||||||
| Rare | SERPINB3 | SERPINB13 | SERPINE3 | SERPINH1 |
Figure 4Biological processes (A), cellular components (B), and molecular functions (C) associated with the highly abundant aqueous humor proteins (detected in >50% samples). Bioinformatics analysis was performed in order to associate significantly enriched Gene Ontology (GO) terms to the constitutive aqueous humor proteome. The horizontal bars represent the number of proteins annotated to each GO term, and the black lines represent the p-value of enrichment.
Figure 5Three top-scoring interaction networks of highly abundant aqueous humor proteins. Ingenuity Pathway Analysis (IPA) was performed on the 243 proteins detected in at least half of the aqueous humor samples. (A) Network 1: includes several members of the Apolipoprotein, Complement, and SERPIN families. (B) Network 2: Network of proteins involved in tissue development, protein synthesis, and cellular compromise. (C) Network 3: Protein cluster associated with humoral immune response, inflammatory response, and protein synthesis. Each protein is represented as a node, and edges represent interactions between proteins. The intensity of color represents the relative levels of proteins (brighter red nodes indicate higher levels). Proteins are separated based on the cellular compartments.
Canonical pathways enriched in the constitutive aqueous humor proteome.
| Canonical Pathway | # of Proteins | |
|---|---|---|
| Acute Phase Response Signaling | 5.01 × 10−42 | 40 |
| LXR/RXR Activation | 5.01 × 10−38 | 33 |
| FXR/RXR Activation | 1.00 × 10−35 | 32 |
| Complement System | 1.00 × 10−24 | 17 |
| Coagulation System | 2.00 × 10−19 | 14 |
| Clathrin-mediated Endocytosis Signaling | 1.58 × 10−12 | 18 |
| Atherosclerosis Signaling | 3.98 × 10−12 | 15 |
| IL-12 Signaling and Production in Macrophages | 1.00 × 10−10 | 14 |
| Extrinsic Prothrombin Activation Pathway | 1.15 × 10−10 | 7 |
| Intrinsic Prothrombin Activation Pathway | 3.55 × 10−10 | 9 |
| Production of Nitric Oxide and Reactive Oxygen Species in Macrophages | 1.02 × 10−8 | 14 |
| Hepatic Fibrosis/Hepatic Stellate Cell Activation | 6.92 × 10−8 | 13 |
| Maturity Onset Diabetes of Young (MODY) Signaling | 1.74 × 10−7 | 8 |
| Airway Pathology in Chronic Obstructive Pulmonary Disease | 3.63 × 10−6 | 9 |
| Systemic Lupus Erythematosus Signaling | 4.68 × 10−6 | 12 |
| Neuroprotective Role of THOP1 in Alzheimer’s Disease | 2.63 × 10−5 | 8 |
| GP6 Signaling Pathway | 2.29 × 10−4 | 7 |
| Iron homeostasis signaling pathway | 5.37 × 10−4 | 7 |
| Actin Cytoskeleton Signaling | 0.002 | 8 |
| Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis | 0.016 | 8 |
| Glucocorticoid Receptor Signaling | 0.021 | 10 |
Proteins with significant differences between African American and Caucasian subjects.
| UniProt ID | Gene Symbol | Description | Fold Change | Adj. | Pathway |
|---|---|---|---|---|---|
| Upregulated in African American subjects | |||||
| P01593 | IGKV1D-33 | Immunoglobulin kappa variable 1D-33 | 2.191 | 0.024 | Complement activation |
| P08294 | SOD3 | Extracellular superoxide dismutase [Cu-Zn] | 2.190 | 0.017 | Antioxidant, Heparin binding |
| P00736 | C1R | Complement C1r subcomponent | 2.182 | 0.014 | Complement activation, classical pathway |
| P08603 | CFH | Complement factor H | 1.865 | 0.021 | Complement activation, alternative pathway |
| P01023 | A2M | Alpha-2-macroglobulin | 1.489 | 0.047 | Blood coagulation |
| P01024 | C3 | Complement C3 | 1.289 | 0.047 | Endopeptidase inhibitor activity |
| Downregulated in African American subjects | |||||
| Q8NG11 | TSPAN14 | Tetraspanin-14 | −2.089 | 0.005 | Cellular protein metabolic process |
| P02753 | RBP4 | Retinol-binding protein 4 | −1.753 | 0.002 | Retinal and retinol binding |
| P02766 | TTR | Transthyretin | −1.751 | <0.001 | Hormone activity |
| P07998 | RNASE1 | Ribonuclease pancreatic | −1.636 | 0.002 | Nucleic acid binding |
| P41222 | PTGDS | Prostaglandin-H2 D-isomerase | −1.435 | 0.002 | Fatty acid binding |
Figure 6Race-specific differences in human aqueous humor proteins. A total of six proteins were upregulated (A) and five proteins were downregulated (B) in African American subjects as compared to Caucasian subjects.